Suppr超能文献

酒精性和特发性慢性胰腺炎中的PRSS1和SPINK1突变

PRSS1 and SPINK1 Mutations in Alcoholic and Idiopathic Chronic Pancreatitis.

作者信息

Liu Xian, Tu Min, Dai Xinglong, Zhu Yi, Ge Qianqian, Gao Wentao, Miao Yi

出版信息

J Nanosci Nanotechnol. 2017 Apr;17(4):2358-362. doi: 10.1166/jnn.2017.12626.

Abstract

Several recent studies have reported associations between gene mutations and chronic pancreatitis (CP); however, little is known about their association with risk of CP in the Chinese Han population. The aim of this study was to describe mutations in the cationic trypsinogen (PRSS1) and serine protease inhibitor Kazal type 1 (SPINK1) genes in patients with alcoholic chronic pancreatitis (ACP) and idiopathic chronic pancreatitis (ICP) and to investigate their influence on the clinical course of the disease. One hundred patients (24 with ACP, 76 with ICP) and 100 healthy volunteers (control group) were enrolled in the study. PRSS1 (R122H) mutations were detected in one (1.3%) patient with ICP and SPINK1 (N34S) mutations were present in one (4.1%) patient with ACP. PRSS1 and SPINK1 mutations were not detected in the control populations. There were no statistically significant differences between the CP patients and the control group. Those preliminary data suggest low prevalence of SPINK1 and PRSS1 mutations in the Chinese population, generally, as well as in CP patients, indicating that these mutations do not contribute to the development of CP.

摘要

最近的几项研究报告了基因突变与慢性胰腺炎(CP)之间的关联;然而,关于它们与中国汉族人群CP风险的关联却知之甚少。本研究的目的是描述酒精性慢性胰腺炎(ACP)和特发性慢性胰腺炎(ICP)患者中阳离子胰蛋白酶原(PRSS1)和丝氨酸蛋白酶抑制剂Kazal型1(SPINK1)基因的突变情况,并研究它们对疾病临床进程的影响。本研究纳入了100例患者(24例ACP患者,76例ICP患者)和100名健康志愿者(对照组)。在1例(1.3%)ICP患者中检测到PRSS1(R122H)突变,在1例(4.1%)ACP患者中检测到SPINK1(N34S)突变。在对照人群中未检测到PRSS1和SPINK1突变。CP患者与对照组之间无统计学显著差异。这些初步数据表明,一般而言,中国人群以及CP患者中SPINK1和PRSS1突变的发生率较低,表明这些突变与CP的发生无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验